ESO/L. Calçada, Exeter/Kraus et al. ALMA and SPHERE view of GW Orionis (side-by-side) ALMA and SPHERE view of GW Orionis (superimposed) ...
Roche has bolstered its R&D pipeline in oncology and neuroscience with a pair of partnerships with Orionis Biosciences and PeptiDream, parting with upfront cash of $87 million for projects in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results